Strokes, cutis marmorata telangiectatica congenita, and factor V Leiden

Pediatric Neurology

Volumn 18, Issue 4, 1998, Pages 342-345

  Gruppo, Ralph A ^a   DeGrauw, Ton J ^a   Palasis, Susan ^a   Kalinyak, Karen A ^a   Bofinger, Mary K ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ARTICLE; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR DISEASE; FEMALE; HUMAN; INFANT; PRIORITY JOURNAL; STROKE; TELANGIECTASIA; THROMBOPHILIA;

ABNORMALITIES, MULTIPLE; BLOOD COAGULATION DISORDERS; BRAIN EDEMA; CEREBRAL ANGIOGRAPHY; CEREBRAL INFARCTION; DISEASE SUSCEPTIBILITY; FACTOR V; FEMALE; HETEROZYGOTE; HIP DISLOCATION, CONGENITAL; HUMANS; INFANT; LEG LENGTH INEQUALITY; MOYAMOYA DISEASE; PROTEIN C; SEIZURES; SKIN DISEASES, VASCULAR; URINARY TRACT INFECTIONS; VITREOUS BODY;

EID: 0031895647     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00176-8     Document Type: Article

References (11)

1. South DA, Jacobs AH. Cutis marmorata telangiectatica congenita (congenital generalized phlebectasia). J Pediatr 1978;93:944-9.
2. Pehr K, Moroz B. Cutis marmorata telangiectatica congenita: Long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism. Pediatr Dermatol 1993;10: 6-11.
3. Baxter P, Gardner-Medwin D, Green SH, Moss C. Congenital livedo reticularis and recurrent stroke-like episodes. Dev Med Child Neurol 1993;35:917-21.
4. Gruppo R, Glueck CJ, Brandt G, et al. Detection of the Factor V Leiden gene mutation in children: Comparison of various modifications of the functional activated protein C resistance test [Abstract]. Thromb Haemost 1997;77(Suppl):18.
5. Ueki K, Meyer FB, Mellinger JF. Moyamoya disease: The disorder and surgical treatment. Mayo Clin Proc 1994;69:749-57.
6. Pavlakis SG, Zito J, Gould RJ. Stroke in children. Adv Pediatr 1991;38:151-79.
7. Gobel U. Inherited or acquired disorders of blood coagulation in children with neurovascular complications. Neuropediatrics 1994;25:4-7.
8. Schoning M, Klein R, Krageloh-Mann I, et al. Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994;25:8-14.
9. Nowak-Gottl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996;92:992-8.
10. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and Factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995;74:449-53.
11. Raja H, Font RL, Reeser F. Persistent hyperplastic primary vitreous: A clinicopathologic study of 62 cases and review of the literature. Surv Ophthalmol 1978;23:123-34.